Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Deutsche Bank analysts upgraded International Paper Company PFD $4 (OTC:INPAP) from Hold to Buy on July 31, 2026. Market Context International Paper Company PFD $4…
Read moreRating Change Truist Securities analysts reiterated a Buy rating on International Paper Company PFD $4 (OTC:INPAP) on July 31, 2026. Market Context International Paper Company PFD…
Read moreRating Change Barclays analysts reiterated a Overweight rating on FirstEnergy Corp. (NYSE:FE) on July 31, 2026. Market Context FirstEnergy Corp.
Read moreRating Change BTIG analysts reiterated a Buy rating on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) on July 31, 2026. Market…
Read moreRating Change Benchmark analysts reiterated a Buy rating on MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock (NASDAQ:STRC) on July 31, 2026.…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Intercontinental Exchange, Inc. (NYSE:ICE) on July 31, 2026. Market Context Intercontinental Exchange, Inc.
Read moreRating Change BTIG analysts reiterated a Buy rating on Starbucks Corporation (NASDAQ:SBUX) on July 31, 2026. Market Context Starbucks Corporation operates in the Consumer Cyclical…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Carvana Co. (NYSE:CVNA) on July 31, 2026. Market Context Carvana Co.
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 31, 2026. Market Context Bristol-Myers Squibb Company operates in the…
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 31, 2026. Market Context Bristol-Myers Squibb Company operates…
Read moreRating Change Wells Fargo analysts reiterated a Equal-Weight rating on Bristol-Myers Squibb Company (NYSE:BMY) on July 31, 2026. Market Context Bristol-Myers Squibb Company…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Welltower Inc. (NYSE:WELL) on July 31, 2026. Market Context Welltower Inc.
Read moreRating Change Barclays analysts reiterated a Overweight rating on KKR & Co. Inc. (NYSE:KKR) on July 31, 2026.
Read moreRating Change BTIG analysts reiterated a Buy rating on Stryker Corporation (NYSE:SYK) on July 31, 2026. Market Context Stryker Corporation operates in the Healthcare sector. The…
Read moreRating Change Truist Securities analysts reiterated a Hold rating on Stryker Corporation (NYSE:SYK) on July 31, 2026. Market Context Stryker Corporation operates in the Healthcare…
Read moreRating Change Rosenblatt analysts reiterated a Buy rating on Arm Holdings plc American Depositary Shares (NASDAQ:ARM) on July 31, 2026. Market Context Arm Holdings plc American…
Read moreRating Change Argus Research analysts downgraded Boston Scientific Corporation (NYSE:BSX) from Buy to Hold on July 31, 2026. Market Context Boston Scientific Corporation operates…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated…
Read moreRating Change Barclays analysts reiterated a Overweight rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated operates in the…
Read moreRating Change Keybanc analysts reiterated a Overweight rating on Mastercard Incorporated (NYSE:MA) on July 31, 2026. Market Context Mastercard Incorporated operates in the…
Read more
